Darin K Edwards Selected Research

Messenger RNA (mRNA)

1/2024	Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2.
1/2023	Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection.
1/2023	Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.
11/2022	Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial.
2/2022	Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
1/2022	Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects.
1/2017	Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darin K Edwards Research Topics

Disease

21	COVID-19 02/2024 - 10/2020
16	Infections 05/2024 - 05/2021
6	Inflammation (Inflammations) 01/2023 - 10/2020
4	Breakthrough Infections 02/2022 - 08/2021
4	Weight Loss (Weight Reduction) 02/2022 - 08/2021
2	Severe Acute Respiratory Syndrome 03/2022 - 10/2021
2	Pneumonia (Pneumonitis) 02/2022 - 08/2021
2	Human Influenza (Influenza) 01/2022 - 01/2017
1	Virus Diseases (Viral Diseases) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Acute Lung Injury 10/2021
1	Persistent Infection 01/2021

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 05/2024 - 01/2017
19	2019-nCoV Vaccine mRNA-1273IBA 05/2024 - 10/2020
10	mRNA VaccinesIBA 01/2024 - 01/2017
7	Messenger RNA (mRNA)IBA 01/2024 - 01/2017
5	Neutralizing AntibodiesIBA 11/2022 - 10/2020
3	COVID-19 VaccinesIBA 05/2024 - 10/2021
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2022
3	AntibodiesIBA 01/2023 - 10/2021
2	IgG Receptors (Fc gamma RI)IBA 01/2023 - 11/2022
2	Combined VaccinesIBA 11/2022 - 09/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2022 - 01/2022
2	Viral AntigensIBA 05/2021 - 01/2021
1	Broadly Neutralizing AntibodiesIBA 05/2024
1	Interleukin-10 (Interleukin 10)IBA 01/2024
1	mRNA-1273.214 COVID-19 vaccineIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	CytokinesIBA 01/2022
1	Ad26COVS1IBA 01/2022
1	aluminum sulfate (alum)IBA 10/2021
1	Protein Subunit VaccinesIBA 10/2021
1	AntigensIBA 10/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2017